Abdominal Obesity Global Clinical Trials Review, H1, 2017

2017-02-22
Price :
Published : Feb-2017
No. of Pages : 79
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Abdominal Obesity Therapeutics Clinical Trials 26
Prominent Drugs 27
Latest Clinical Trials News on Abdominal Obesity 28
Dec 23, 2016: Neothetics Initiates Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous Fat 28
Clinical Trial Profile Snapshots 29
Appendix 76
Abbreviations 76
Definitions 76
Research Methodology 77
Secondary Research 77
About GlobalData 78
Contact Us 78
Disclaimer 78
Source 79

List of Tables
Abdominal Obesity Therapeutics, Global, Clinical Trials by Region, 2017* 5
Abdominal Obesity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 6
Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 7
Abdominal Obesity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 8
Abdominal Obesity Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 9
Abdominal Obesity Therapeutics Clinical Trials, North America, Top Countries, 2017* 10
Abdominal Obesity Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 11
Abdominal Obesity Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 12
Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017* 13
Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017* 16
Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18
Abdominal Obesity Therapeutics, Global, Clinical Trials by Phase, 2017* 19
Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 20
Abdominal Obesity Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
Abdominal Obesity Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
Abdominal Obesity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
Abdominal Obesity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 24
Abdominal Obesity Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
Abdominal Obesity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
Abdominal Obesity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27

List of Figures
Abdominal Obesity Therapeutics, Global, Clinical Trials by Region (%), 2017* 5
Abdominal Obesity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 6
Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 7
Abdominal Obesity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 8
Abdominal Obesity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 9
Abdominal Obesity Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 10
Abdominal Obesity Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 11
Abdominal Obesity Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 12
Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017* 13
Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017* 16
Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18
Abdominal Obesity Therapeutics, Global, Clinical Trials by Phase (%), 2017* 19
Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 20
Abdominal Obesity Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
Abdominal Obesity Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
Abdominal Obesity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
Abdominal Obesity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 24
Abdominal Obesity Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
Abdominal Obesity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
Abdominal Obesity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27
GlobalData Methodology 77
Filed in: Uncategorized
Publisher : GlobalData